Bolster our biotech business
22 Mar 2005 by Evoluted New Media
The biotech industry is not devoting sufficient resources to new business strategies, according to speakers at the Evolution of Life Science Industries conference held in Edinburgh.
The biotech industry is not devoting sufficient resources to new business strategies, according to speakers at the Evolution of Life Science Industries conference held in Edinburgh.
Global healthcare spending currently exceeds US$3 trillion, of which pharmaceuticals account for approximately US$250 million. The European Commission sees life sciences and biotechnology as the next wave for the knowledge-based economy.
Managing Director of the Netherlands Biotech Industry, Dr Rob Janssen believes most countries are looking for ways to improve their biotech climate but questions whether they are taking the right measures.
“Countries are investing heavily in scientific research, even when that research is already on a very high level,” he said. “It would be better to invest in measures which are helpful to business.”
“By 2020 Europe will be the world’s top knowledge economy,” said Jose Mariana Gago speaking from the conference. The Evolution of Life Science Industries Conference was held by the Economic and Social Research Council’s centre for Social and Economic Research ion Innovation in Genomics, at the Edinburgh Conference Centre.
Further info –
Professor Joyce Tait, Director Innogen Centre – 0131 650 9174 or joyce.tait@ed.ac.uk
Julie Hamilton Information Officer – 0130 650 2452 or Julie.Hamilton@ed.ac.uk
